| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
Trophoblast glycoprotein, commonly known as 5T4 or TPBG, serves as a compelling target for researchers investigating oncofetal biology, tumor progression, and stem cell dynamics. This leucine-rich repeat glycoprotein shows restricted expression in normal adult tissues but becomes markedly upregulated across numerous carcinomas, making it an attractive focus for cancer immunotherapy development and tumor biology studies. Its role as a Wnt-activated inhibitory factor further positions 5T4 at the intersection of developmental signaling and malignant transformation.
This recombinant monoclonal antibody, generated from clone 6E9 in rabbit host, offers the reproducibility and sequence-defined consistency that demanding experimental workflows require. Unlike traditional hybridoma-derived antibodies, recombinant production eliminates lot-to-lot variability, ensuring your optimization efforts translate reliably across extended studies and collaborative projects.
Validation testing demonstrates robust performance across multiple applications. In western blot analysis, the antibody detects 5T4 in diverse human cancer cell lines including U-87, A549, MCF-7, PC-3, and U-251, as well as mouse brain tissue, confirming cross-species reactivity. The observed bands at approximately 50 and 80 kDa, compared to the predicted 47 kDa molecular weight, reflect the extensive glycosylation characteristic of this trophoblast glycoprotein. The 50 kDa band represents a partially glycosylated precursor protein that exists in the endoplasmic reticulum or Golgi apparatus and has not completed all glycosylation modifications. The 80 kDa band represents a fully glycosylated mature membrane protein, which is the functional active form located on the cell membrane surface. Immunohistochemistry validation in human placenta tissue, where 5T4 is physiologically expressed, confirms suitability for tissue-based studies with recommended dilutions between 1:50 and 1:200.
Whether you are characterizing 5T4 expression in tumor specimens, investigating its function in epithelial-mesenchymal transition, or developing immunotherapeutic strategies, this antibody provides a dependable tool for cancer research, developmental biology, immunology, and stem cell applications.
Email: support@cusabio.com
Distributors Worldwide